Back to UBS Group AG UBS Group AG

NGNENGNE
11 quarters

Position history for UBS Group AGUBS Group AG's holdings in NEUROGENE INC

Yes. Ubs holds 171,289 shares of NGNE (Neurogene), worth $5.4M, as of its Q2 2026 13F filing. It reduced the position by 14,390 shares (-7.8%) from Q1 2026. Ubs has held NGNE since Q4 2023, across 11 quarterly 13F filings.

Current Value

$5.4M

Current Shares

171,289

Total Value Change

+$5.4M

Total Shares Change

+170,289

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
171,289
-7.8%
$5.4M0.0%$31.45
0
2026-Q1
Increased
185,679
+20.5%
$3.7M0.0%$21.99
32
2025-Q4
Decreased
154,123
-32.3%
$3.2M0.0%$22.11
0
2025-Q3
Decreased
227,716
-5.2%
$3.9M0.0%$17.71
0
2025-Q2
Increased
240,319
+15.1%
$3.6M0.0%$16.16
30
2025-Q1
Decreased
208,716
-39.9%
$2.4M0.0%$14.52
0
2024-Q4
Increased
347,201
+6676.0%
$7.9M0.0%$22.28
44
2024-Q3
Increased
5,124
+49.7%
$215,0030.0%$40.33
22
2024-Q2
Decreased
3,423
-64.8%
$124,5630.0%$36.39
0
2024-Q1
Increased
9,718
+871.8%
$494,6470.0%$50.90
39
2023-Q4
New
1,000
-
$19,3800.0%$19.38
29

Other major holders of NGNE: BlackRock, Inc., BlackRock Finance, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used